These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37565234)

  • 21. Analysis of driver and passenger crash injury severity using partial proportional odds models.
    Mooradian J; Ivan JN; Ravishanker N; Hu S
    Accid Anal Prev; 2013 Sep; 58():53-8. PubMed ID: 23702439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of time-to-event data: a comparison of two-stage methods.
    Simmonds MC; Tierney J; Bowden J; Higgins JP
    Res Synth Methods; 2011 Sep; 2(3):139-49. PubMed ID: 26061782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active-control trials with binary data: a comparison of methods for testing superiority or non-inferiority using the odds ratio.
    Siqueira AL; Whitehead A; Todd S
    Stat Med; 2008 Feb; 27(3):353-70. PubMed ID: 17628041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Average Hazard Ratio - A Good Effect Measure for Time-to-event Endpoints when the Proportional Hazard Assumption is Violated?
    Rauch G; Brannath W; Brückner M; Kieser M
    Methods Inf Med; 2018 May; 57(3):89-100. PubMed ID: 29719915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of ordinal regression models applied on health-related quality of life assessments.
    Lall R; Campbell MJ; Walters SJ; Morgan K
    Stat Methods Med Res; 2002 Feb; 11(1):49-67. PubMed ID: 11923993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model-assisted analyses of longitudinal, ordinal outcomes with absorbing states.
    Schildcrout JS; Harrell FE; Heagerty PJ; Haneuse S; Di Gravio C; Garbett SP; Rathouz PJ; Shepherd BE
    Stat Med; 2022 Jun; 41(14):2497-2512. PubMed ID: 35253265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of treatments with ordinal responses in trials with sequential monitoring and response-adaptive randomization.
    Yu Y; Xu C; Zhong J; Cheung SH
    Stat Med; 2022 Nov; 41(25):5061-5083. PubMed ID: 35973712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational issues in fitting joint frailty models for recurrent events with an associated terminal event.
    Toenges G; Jahn-Eimermacher A
    Comput Methods Programs Biomed; 2020 May; 188():105259. PubMed ID: 31862679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DiagTest3Grp: An R Package for Analyzing Diagnostic Tests with Three Ordinal Groups.
    Luo J; Xiong C
    J Stat Softw; 2012 Oct; 51(3):1-24. PubMed ID: 23504300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Model diagnostics for the proportional hazards model with length-biased data.
    Lee CH; Ning J; Shen Y
    Lifetime Data Anal; 2019 Jan; 25(1):79-96. PubMed ID: 29450809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing proportionality in the proportional odds model for ordinal logistic regression.
    Brant R
    Biometrics; 1990 Dec; 46(4):1171-8. PubMed ID: 2085632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline-adjusted proportional odds models for the quantification of treatment effects in trials with ordinal sum score outcomes.
    Buri M; Curt A; Steeves J; Hothorn T
    BMC Med Res Methodol; 2020 May; 20(1):104. PubMed ID: 32375705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Data-driven smooth tests of the proportional hazards assumption.
    Kraus D
    Lifetime Data Anal; 2007 Mar; 13(1):1-16. PubMed ID: 17115257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fitting stratified proportional odds models by amalgamating conditional likelihoods.
    Mukherjee B; Ahn J; Liu I; Rathouz PJ; Sánchez BN
    Stat Med; 2008 Oct; 27(24):4950-71. PubMed ID: 18618428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methods for Multilevel Ordinal Data in Prevention Research.
    Hedeker D
    Prev Sci; 2015 Oct; 16(7):997-1006. PubMed ID: 24939751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proportional odds assumption for modeling longitudinal ordinal multiple toxicity outcomes in dose finding studies of targeted agents: A pooled analysis of 54 studies.
    Drubay D; Collette L; Paoletti X
    Contemp Clin Trials Commun; 2020 Mar; 17():100529. PubMed ID: 32055745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Bayesian goodness of fit test and semiparametric generalization of logistic regression with measurement data.
    Schörgendorfer A; Branscum AJ; Hanson TE
    Biometrics; 2013 Jun; 69(2):508-19. PubMed ID: 23489010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testing the proportional hazards assumption in case-cohort analysis.
    Xue X; Xie X; Gunter M; Rohan TE; Wassertheil-Smoller S; Ho GY; Cirillo D; Yu H; Strickler HD
    BMC Med Res Methodol; 2013 Jul; 13():88. PubMed ID: 23834739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of hypothesis tests for homogeneity in meta-analysis with focus on rare binary events.
    Zhang C; Wang X; Chen M; Wang T
    Res Synth Methods; 2021 Jul; 12(4):408-428. PubMed ID: 34231330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Power and sample size for GEE analysis of incomplete paired outcomes in 2 × 2 crossover trials.
    Tang Y
    Pharm Stat; 2021 Jul; 20(4):820-839. PubMed ID: 33738918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.